Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Intravenous Fish Oil Emulsion on Inflammatory Markers, Organ Function, Muscle Mass, Physical Function, and Clinical Outcomes in Critically Ill Patients With High Inflammatory Status. A Phase II, Single-blind, Dose-finding, Randomized Controlled Trial

NCT07883447 is registered in ClinicalTrials.gov with Lee Zheng Yii as lead sponsor.

NCT NCT07883447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07883447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Intravenous Fish Oil Emulsion on Inflammatory Markers, Organ Function, Muscle Mass, Physical Function, and Clinical Outcomes in Critically Ill Patients With High Inflammatory Status. A Phase II, Single-blind, Dose-finding, Randomized Controlled Trial
Lead sponsor
Lee Zheng Yii
Phase
Phase 2
Overall status
Recruiting
Start date
July 7, 2026
Completion date
July 7, 2029
Enrollment
159 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness